152 related articles for article (PubMed ID: 18502145)
21. Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: a potential role of interleukin-7.
Bortolin MT; Tedeschi R; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
Cytokine; 2012 Oct; 60(1):90-5. PubMed ID: 22795293
[TBL] [Abstract][Full Text] [Related]
22. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
[TBL] [Abstract][Full Text] [Related]
23. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.
Fujimura K; Ebinuma H; Fukamachi I; Ohwada C; Kawaguchi T; Shimizu N; Takeuchi M; Sakaida E; Jiang M; Nakaseko C; Bujo H
Clin Chim Acta; 2014 Mar; 430():48-54. PubMed ID: 24394293
[TBL] [Abstract][Full Text] [Related]
24. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
[TBL] [Abstract][Full Text] [Related]
25. Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas.
Stasi R; Conforti M; Del Poeta G; Simone MD; Coppetelli U; Tribalto M; Cantonetti M; Perrotti A; Venditti A; Papa G
Haematologica; 1992; 77(6):518-21. PubMed ID: 1289190
[TBL] [Abstract][Full Text] [Related]
26. [Clinical value of combined detection of LDH, TPS, CEA and beta2-MG in patients with non- Hodgkin's lymphoma].
Chen W; Luo RC; Fan WW; Ma SD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):227-8, 230. PubMed ID: 16503538
[TBL] [Abstract][Full Text] [Related]
27. Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment.
Passam FH; Sfiridaki A; Pappa C; Kyriakou D; Petreli E; Roussou PA; Alexandrakis MG
Int J Lab Hematol; 2008 Feb; 30(1):17-25. PubMed ID: 18190463
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
29. Lipid profile as a prognostic factor in cancer patients.
Cvetkovic Z; Cvetkovic B; Petrovic M; Ranic M; Debeljak-Martarcic J; Vucic V; Glibetic M
J BUON; 2009; 14(3):501-6. PubMed ID: 19810145
[TBL] [Abstract][Full Text] [Related]
30. [Interleukin-17 concentration in serum and urine of children with idiopathic nephrotic syndrome].
Kiliś-Pstrusińska K; Zwolińska D; Medyńska A; Wawro A; Kordecki H
Przegl Lek; 2006; 63 Suppl 3():198-200. PubMed ID: 16898529
[TBL] [Abstract][Full Text] [Related]
31. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
Hosny G; Farahat N; Hainaut P
Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
[TBL] [Abstract][Full Text] [Related]
32. Serum CA 125 levels in children with non-Hodgkin's lymphoma.
Kutluk T; Varan A; Erbaş B; Büyükpamukçu M
Pediatr Hematol Oncol; 1999; 16(4):311-9. PubMed ID: 10407867
[TBL] [Abstract][Full Text] [Related]
33. [Plasma interleukin-6 and interleukin-10 levels in different subtypes of lymphoma and their clinical significance].
Wang X; Zhao HR; Gu X; Liu P; Bikmituofu H
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1360-4. PubMed ID: 21868324
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma.
Wu L; Wang T; Gui W; Lin H; Xie K; Wang H; Gao T; Zhang X; Liu L; Han T; Tian Y; Hou L
Oncology; 2014; 87(1):40-7. PubMed ID: 24969158
[TBL] [Abstract][Full Text] [Related]
35. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis.
Sheu JN; Chen MC; Lue KH; Cheng SL; Lee IC; Chen SM; Tsay GJ
Cytokine; 2006 Dec; 36(5-6):276-82. PubMed ID: 17374489
[TBL] [Abstract][Full Text] [Related]
36. Soluble interleukin-2 receptor levels in patients with non-Hodgkin's lymphoma or with acute leukemia.
Chang CS; Lin SF; Liu HW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 May; 21(2):79-84. PubMed ID: 3264231
[TBL] [Abstract][Full Text] [Related]
37. Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies.
Bouafia F; Drai J; Bienvenu J; Thieblemont C; Espinouse D; Salles G; Coiffier B
Bull Cancer; 2004; 91(7-8):E229-40. PubMed ID: 15381461
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
[TBL] [Abstract][Full Text] [Related]
39. Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma.
Herishanu Y; Perry C; Braunstein R; Metser U; Goor O; Rogowski O; Berliner S; Polliack A; Naparstek E
Eur J Haematol; 2007 Aug; 79(2):150-4. PubMed ID: 17635239
[TBL] [Abstract][Full Text] [Related]
40. [Fibroblast growth factor (b-FGF) in serum and urine of patients with head-neck malignancies].
Leunig A; Spaett R; Tauber S; Leunig M; Grevers G
Laryngorhinootologie; 1997 Jul; 76(7):421-4. PubMed ID: 9333294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]